Related Experiment Videos
Enhancing the diagnosis of fabry disease in cardiology with a targeted information: a before-after control-impact
Anne-Louise Savary1, Remy Morello2, Carole Brasse-Lagnel3
1Department of Cardiology, CHU de Caen, Caen, France.
Insights
Targeted education for cardiologists on Fabry disease significantly improved screening, leading to the diagnosis of two new cases. This strategy is valuable for early detection and treatment of Fabry disease.
Area of Science:
- Cardiology
- Genetics
- Rare Diseases
Background:
- Fabry disease frequently causes cardiac complications, particularly left ventricular hypertrophy.
- Cardiologists play a crucial role in identifying Fabry disease due to cardiac manifestations.
- Early diagnosis and treatment of Fabry disease can be improved by equipping cardiologists with targeted information.
Purpose of the Study:
- To evaluate the effectiveness of providing cardiologists with targeted information on Fabry disease for screening purposes.
- To assess the impact of an educational intervention on Fabry disease diagnosis rates among cardiologists.
Main Methods:
- A before-after control-impact study design was employed.
- Cardiologists received educational materials including a booklet, oral information, and screening kits.
- Screening for Fabry disease using dried blood spots was conducted in patients with cardiac conditions over a 12-month period.
Main Results:
- Forty-two cardiologists participated; none had diagnosed Fabry disease in the preceding three years.
- Screening of 55 patients with cardiac monitoring identified two new cases of Fabry disease (3.4% prevalence).
- The educational intervention was rated as relevant and useful for clinical practice.
Conclusions:
- Targeted information empowers cardiologists to diagnose Fabry disease more effectively.
- This educational strategy directly led to the identification of two new families with Fabry disease.
- The study highlights the clinical impact of specialized education in rare disease diagnosis.
Background:
Cardiac complications in Fabry disease are frequent and dominated by a high frequency of left ventricular hypertrophy; therefore, cardiologists may have an essential role in screening for this disease. Providing cardiologists with targeted information on Fabry disease would be valuable and could reduce both diagnostic and therapeutic delays. The aim of this study was to evaluate the efficiency of such strategy for Fabry screening.
Methods:
We conducted a before-after control-impact study by comparing observations made before and after targeted information on Fabry disease among cardiologists. The information on Fabry disease consisted of (1) an educational booklet, (2) oral information and (3) screening kits. The programme was evaluated at the end of a 12-month study period.
Results:
Forty-two cardiologists participated to this study. None of them had conducted screening test and new diagnostic for Fabry disease in the 3 years prior the information. After the information, screening with dried blood spots was performed in 55 patients (ranged 18-77 years, men: 39) with cardiac monitoring for supposed sarcomeric hypertrophic cardiomyopathy (n=41) or unexplained left ventricular hypertrophy (n=14) from January 2015 to January 2016. Two new cases of Fabry disease were diagnosed (3.4%) in two men (ages 58 and 51 years). The information was deemed relevant in both content and structure and was deemed useful for everyday practice.
Conclusion:
Cardiologists valued the targeted information on Fabry disease. This information had a direct clinical impact by allowing the diagnosis of two new families with Fabry disease.